A chemical biological strategy to facilitate diabetic wound healing

ACS Chemical Biology

Volumn 9, Issue 1, 2014, Pages 105-110

  Gooyit, Major ^a   Peng, Zhihong ^a   Wolter, William R ^a   Pi, Hualiang ^a   Ding, Derong ^a   Hesek, Dusan ^a   Lee, Mijoon ^a   Boggess, Bill ^a   Champion, Matthew M ^a   Suckow, Mark A ^a   Mobashery, Shahriar ^a   Chang, Mayland ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MATRIX METALLOPROTEINASE 8 INHIBITOR; MATRIX METALLOPROTEINASE 9 INHIBITOR; MATRIX METALLOPROTEINASE INHIBITOR; ND 322; NEUTROPHIL COLLAGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC WOUND HEALING; EPITHELIZATION; INTERVENTION STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOPICAL TREATMENT; WOUND HEALING; WOUND HEALING IMPAIRMENT;

ANIMALS; DIABETES COMPLICATIONS; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; MICE; MODELS, MOLECULAR; WOUND HEALING;

EID: 84898867762     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb4005468     Document Type: Article

References (29)

1. Centers for Disease Control and Prevention. (2011) 2011 National Diabetes Fact Sheet, Centers for Disease Control and Prevention, Atlanta, GA.
2. Mustoe, T. (2004) Understanding chronic wounds: A unifying hypothesis on their pathogenesis and implications for therapy. Am. J. Surg. 187, 65S-70S. (Pubitemid 38625990)
3. Alleva, R., Nasole, E., Di Donato, F., Borghi, B., Neuzil, J., and Tomasetti, M. (2005) ?-Lipoic acid supplementation inhibits oxidative damage, accelerating chronic wound healing in patients undergoing hyperbaric oxygen therapy. Biochem. Biophys. Res. Commun. 333, 404-410. (Pubitemid 40848305)
4. Dalton, S. J., Mitchell, D. C., Whiting, C. V., and Tarlton, J. F. (2005) Abnormal extracellular matrix metabolism in chronically ischemic skin: A mechanism for dermal failure in leg ulcers. J. Invest. Dermatol. 125, 373-379. (Pubitemid 41648172)
5. Rayment, E. A., Upton, Z., and Shooter, G. K. (2008) Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer. Br. J. Dermatol. 158, 951-961. (Pubitemid 351521431)
6. Toth, M., and Fridman, R. (2001) Assessment of gelatinases (MMP-2 and MMP-9 by gelatin zymography. Methods Mol. Med. 57, 163-174.
7. Agrawal, S. M., Lau, L., and Yong, V. W. (2008) MMPs in the central nervous system: Where the good guys go bad. Semin. Cell Dev. Biol. 19, 42-51. (Pubitemid 350235982)
8. Fisher, J. F., and Mobashery, S. (2010) Mechanism-based profiling of MMPs, in Matrix Metalloproteinase Protocols (Clark, I. M., Ed.), pp 471-487, Humana Press, New York.
9. Barglow, K. T., and Cravatt, B. F. (2007) Activity-based protein profiling for the functional annotation of enzymes. Nat. Methods 4, 822-827. (Pubitemid 350055579)
10. Evans, M. J., and Cravatt, B. F. (2006) Mechanism-based profiling of enzyme families. Chem. Rev. 106, 3279-3301. (Pubitemid 44376936)
11. Saghatelian, A., Jessani, N., Joseph, A., Humphrey, M., and Cravatt, B. F. (2004) Activity-based probes for the proteomic profiling of metalloproteases. Proc. Natl. Acad. Sci. U.S.A. 101, 10000-10005. (Pubitemid 38891185)
12. Sieber, S. A., and Cravatt, B. F. (2006) Analytical platforms for activity-based protein profiling-Exploiting the versatility of chemistry for functional proteomics. Chem. Commun. (Camb.), 2311-2319. (Pubitemid 43846363)
13. Sieber, S. A., Niessen, S., Hoover, H. S., and Cravatt, B. F. (2006) Proteomic profiling of metalloprotease activities with cocktails of active-site probes. Nat. Chem. Biol. 2, 274-281.
14. Freije, J. R., and Bischoff, R. (2003) Activity-based enrichment of matrix metalloproteinases using reversible inhibitors as affinity ligands. J. Chromatogr. A 1009, 155-169. (Pubitemid 36966680)
15. Freije, J. R., Klein, T., Ooms, J. A., Franke, J. P., and Bischoff, R. (2006) Activity-based matrix metallo-protease enrichment using automated, inhibitor affinity extractions. J. Proteome Res. 5, 1186-1194. (Pubitemid 43727797)
16. Freije, R., Klein, T., Ooms, B., Kauffman, H. F., and Bischoff, R. (2008) An integrated high-performance liquid chromatography-mass spectrometry system for the activity-dependent analysis of matrix metalloproteases. J. Chromatogr. A 1189, 417-425. (Pubitemid 351508270)
17. Hesek, D., Toth, M., Krchnak, V., Fridman, R., and Mobashery, S. (2006) Synthesis of an inhibitor-tethered resin for detection of active matrix metalloproteinases involved in disease. J. Org. Chem. 71, 5848-5854. (Pubitemid 44200248)
18. Sullivan, S. R., Underwood, R. A., Gibran, N. S., Sigle, R. O., Usui, M. L., Carter, W. G., and Olerud, J. E. (2004) Validation of a model for the study of multiple wounds in the diabetic mouse (db/ db). Plast. Reconstr. Surg. 113, 953-960. (Pubitemid 39195758)
19. Galiano, R. D., Michaels, J. t., Dobryansky, M., Levine, J. P., and Gurtner, G. C. (2004) Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen. 12, 485-492. (Pubitemid 39007049)
20. Lobmann, R., Ambrosch, A., Schultz, G., Waldmann, K., Schiweck, S., and Lehnert, H. (2002) Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and nondiabetic patients. Diabetologia 45, 1011-1016. (Pubitemid 34762196)
21. Wall, S. J., Bevan, D., Thomas, D. W., Harding, K. G., Edwards, D. R., and Murphy, G. (2002) Differential expression of matrix metalloproteinases during impaired wound healing of the diabetes mouse. J. Invest. Dermatol. 119, 91-98. (Pubitemid 35304396)
22. Gutierrez-Fernandez, A., Inada, M., Balbin, M., Fueyo, A., Pitiot, A. S., Astudillo, A., Hirose, K., Hirata, M., Shapiro, S. D., Noel, A., Werb, Z., Krane, S. M., Lopez-Otin, C., and Puente, X. S. (2007) Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8). FASEB J. 21, 2580-2591. (Pubitemid 47230686)
23. Forbes, C., Shi, Q., Fisher, J. F., Lee, M., Hesek, D., Llarrull, L. I., Toth, M., Gossing, M., Fridman, R., and Mobashery, S. (2009) Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases. Chem. Biol. Drug Des. 74, 527-534.
24. Gooyit, M., Lee, M., Schroeder, V. A., Ikejiri, M., Suckow, M. A., Mobashery, S., and Chang, M. (2011) Selective water-soluble gelatinase inhibitor prodrugs. J. Med. Chem. 54, 6676-6690.
25. Pochetti, G., Montanari, R., Gege, C., Chevrier, C., Taveras, A. G., and Mazza, F. (2009) Extra binding region induced by non-zinc chelating inhibitors into the S1? subsite of matrix metalloproteinase 8 (MMP-8). J. Med. Chem. 52, 1040-1049.
26. Gu, Z., Kaul, M., Yan, B., Kridel, S. J., Cui, J., Strongin, A., Smith, J. W., Liddington, R. C., and Lipton, S. A. (2002) Snitrosylation of matrix metalloproteinases: Signaling pathway to neuronal cell death. Science 297, 1186-1190. (Pubitemid 36193354)
27. Mirastschijski, U., Haaksma, C. J., Tomasek, J. J., and Agren, M. S. (2004) Matrix metalloproteinase inhibitor GM 6001 attenuates keratinocyte migration, contraction, and myofibroblast formation in skin wounds. Exp. Cell Res. 299, 465-475. (Pubitemid 39179812)
28. Agren, M. S. (1999) Matrix metalloproteinases (MMPs) are required for re-epithelialization of cutaneous wounds. Arch. Dermatol. Res. 291, 583-590.
29. Agren, M. S., Mirastschijski, U., Karlsmark, T., and Saarialho-Kere, U. K. (2001) Topical synthetic inhibitor of matrix metalloproteinases delays epidermal regeneration of human wounds. Exp. Dermatol. 10, 337-348. (Pubitemid 32916283)